These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 11379375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D, Posea C, Ceausu I, Rusu M.
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [Abstract] [Full Text] [Related]

  • 3. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.
    Basson R, Brotto LA.
    BJOG; 2003 Nov; 110(11):1014-24. PubMed ID: 14592587
    [Abstract] [Full Text] [Related]

  • 6. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Nov; 16(5):923-31. PubMed ID: 19424093
    [Abstract] [Full Text] [Related]

  • 7. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Nov; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 8. Effects of tibolone and raloxifene on health-related quality of life and sexual function.
    Nijland EA, Weijmar Schultz WC, Davis SR.
    Maturitas; 2007 Oct 20; 58(2):164-73. PubMed ID: 17870260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE.
    Climacteric; 2001 Dec 20; 4(4):314-9. PubMed ID: 11770188
    [Abstract] [Full Text] [Related]

  • 13. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
    Nathorst-Böös J, Flöter A, Jarkander-Rolff M, Carlström K, Schoultz Bv.
    Maturitas; 2006 Jan 10; 53(1):11-8. PubMed ID: 16183220
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Female sexual arousal: relation between cognitive and genital assessments.
    Schreiner-Engel P, Schiavi RC, Smith H.
    J Sex Marital Ther; 1981 Jan 10; 7(4):256-67. PubMed ID: 7328680
    [Abstract] [Full Text] [Related]

  • 16. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C, Keramopoulos D, Vourli G, Gaki V, Bredakis N, Keramopoulos A.
    Climacteric; 2005 Dec 10; 8(4):342-51. PubMed ID: 16390769
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
    Cayan F, Dilek U, Pata O, Dilek S.
    J Sex Med; 2008 Jan 10; 5(1):132-8. PubMed ID: 17961145
    [Abstract] [Full Text] [Related]

  • 18. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK, Ahn JY, Jin DK, Yoon BK, Kim HS, Kim DS, Kang WC, Han SH, Choi IS, Shin EK.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1889-94. PubMed ID: 12933531
    [Abstract] [Full Text] [Related]

  • 19. Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial.
    Kubista E, Planellas Gomez JV, Dowsett M, Foidart JM, Pohlodek K, Serreyn R, Nechushkin M, Manikhas AG, Semiglazov VF, Hageluken CC, Singer CF.
    Clin Cancer Res; 2007 Jul 15; 13(14):4185-90. PubMed ID: 17634547
    [Abstract] [Full Text] [Related]

  • 20. Tibolone (Livial) enhances warfarin-induced anticoagulation in postmenopausal women.
    Elbers J, Hageluken C, Wadham A.
    Maturitas; 2007 Jan 20; 56(1):94-100. PubMed ID: 16887301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.